Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Topical E6201 Gel in Psoriasis Vulgaris
NCT01268527Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of e6201 in Psoriasis vulgaris (PV), sponsored by Eisai Co., Ltd.. Started Mar 2010; status: completed.
02
Drugs
e6201
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01268527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01268527.